Small Companies Turning To CDER Ombudsman For Help With Drug Approvals
This article was originally published in The Pink Sheet Daily
Executive Summary
While the CDER ombudsman dealt with far fewer complaints overall in 2011 than in 2010 due to administrative changes, smaller companies are increasingly asking for help in certain key areas of drug development.